Forest Laboratories Inc (NYSE:FRX)
During the Trading Day
| 37.92 |  -0.06 / -0.16% |
Data as of 4:01pm ET | Day’s Change |
During After-Hours Switch to standard view »
| 37.92 |  0.00 / 0.00% |
Volume: 20.8K |
Latest FRX News | Press Releases
| July Options Now Available For Forest Laboratories (FRX) May 20 / TheStreet.com | Forest-Trevena Ink Deal - Analyst Blog May 14 / Zacks.com |
| Forest Reaches New 52-Week High (FRX) May 14 / TheStreet.com | Positive Data on Forest Combo Drug - Analyst Blog May 07 / Zacks.com |
Today’s Trading
| Previous close | 37.98 |
| Today’s open | 37.92 |
| Day’s range | 37.69 - 38.07 |
| Volume | 658,854 |
| Average volume (3 months) | 1,331,188 |
| Market cap | $10.1B |
| Dividend yield | -- |
Data as of 4:01pm ET, 05/21/2013
Growth & Valuation
| Earnings growth (last year) | -0.56% |
| Earnings growth (this year) | -88.97% |
| Earnings growth (next 5 years) | +37.00% |
| Revenue growth (last year) | +4.26% |
| P/E ratio | NM |
| Price/Sales | 2.16 |
| Price/Book | 1.78 |
Competitors
| Today’s change | Today’s % change | |
|---|---|---|
| PRGOPerrigo Co | -0.38 | -0.32% |
| BMRNBioMarin Pharmaceuti... | +2.57 | +4.12% |
| MYLMylan Inc | -0.05 | -0.16% |
| ONXXOnyx Pharmaceuticals... | -1.43 | -1.52% |
Data as of 4:00pm ET, 05/21/2013
Financials
| Next reporting date | July 23, 2013 |
| EPS forecast (this quarter) | $0.10 |
| Annual revenue (last year) | $4.4B |
| Annual profit (last year) | $979.1M |
| Net profit margin | 22.29% |
Profile
Sector Health Technology |
Industry Pharmaceuticals: Other |
Chairman, President & Chief Executive Officer Howard Solomon |
Senior Vice President & Operations Director Kevin Walsh |
Corporate headquarters New York, New York |
Forecasts
